Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Showa Sangyo, 4% Decrease in Ordinary Profit for The Current Fiscal Year
2004 Showa Sangyo Co., Ltd. 【J-GAAP】
Earnings ReportShowa Sangyo Co., Ltd. <2004> [TSE Prime] announced its financial results after the market closed on May 12th (15:30). The consolidated ordinary profit for the fiscal year ending March 2025 decreased 17.9% from the previous period to 13.5 billion yen. For the fiscal year ending March 2026, the consolidated ordinary profit is expected to decrease by 4.3% from the previous period to 13 billion yen.
In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit dropped to 1.54 billion yen, a 36.2% decrease compared to the same period last year. The operating profit margin worsened from 2.3% in the same period last year to 1.8%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2023 | 335,053 | 4,184 | 6,525 | 7,776 | 232.6 | 65 | May 11, 2023 | J-GAAP |
| Mar, 2024 | 346,358 | 13,146 | 16,558 | 12,358 | 369.4 | 80 | May 13, 2024 | J-GAAP |
| Mar, 2025 | 334,425 | 11,126 | 13,591 | 11,599 | 356.0 | 100 | May 12, 2025 | J-GAAP |
| YoY | -3.4% | -15.4% | -17.9% | -6.1% | -3.6% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2025 Guidance | 346,000 | 12,000 | 13,000 | 11,000 | 338.7 | 100 | Feb 7, 2025 | J-GAAP |
| Mar, 2025 Results | 334,425 | 11,126 | 13,591 | 11,599 | 356.0 | 100 | May 12, 2025 | J-GAAP |
| Revision Rate | -3.3% | -7.3% | +4.5% | +5.4% | +5.1% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2024 | 168,582 | 6,867 | 8,262 | 7,586 | 232.1 | 40 | Nov 8, 2024 | J-GAAP |
| Apr - Sep, 2025 Guidance | ー | ー | ー | ー | - | 50 | May 12, 2025 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 346,358 | 13,146 | 16,558 | 12,358 | 369.4 | 80 | May 13, 2024 | J-GAAP |
| Mar, 2025 | 334,425 | 11,126 | 13,591 | 11,599 | 356.0 | 100 | May 12, 2025 | J-GAAP |
| Mar, 2026 Guidance | 340,000 | 11,000 | 13,000 | 9,500 | 292.3 | 100 | May 12, 2025 | J-GAAP |
| YoY | +1.7% | -1.1% | -4.3% | -18.1% | -17.9% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2024 | 80,803 | 1,827 | 2,421 | 1,996 | 59.7 | 2.3 | May 13, 2024 | J-GAAP |
| Apr - Jun, 2024 | 85,929 | 4,118 | 5,191 | 5,322 | 161.7 | 4.8 | Aug 5, 2024 | J-GAAP |
| Jul - Sep, 2024 | 82,653 | 2,749 | 3,071 | 2,264 | 69.3 | 3.3 | Nov 8, 2024 | J-GAAP |
| Oct - Dec, 2024 | 87,087 | 2,878 | 3,784 | 2,811 | 86.2 | 3.3 | Feb 7, 2025 | J-GAAP |
| Jan - Mar, 2025 | 78,756 | 1,381 | 1,545 | 1,202 | 36.9 | 1.8 | May 12, 2025 | J-GAAP |
| YoY | -2.5% | -24.4% | -36.2% | -39.8% | -38.2% |
Related Articles
SAPPORO CLINICAL LAB, 9% Increase in Ordinary Profit for The Current Fiscal Year
MT GENEX, 39% Increase in Ordinary Profit, Record High for The First Time in Fifteen Years
UNIVANCE, 54% Decrease in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 1 yen, This Fiscal Year to Increase Dividend by 2 yen
Medical Data Vision, Jan-Mar (1Q) Ordinary Profit Decreases by 9%
PALTAC, 2% Increase in Ordinary Profit, Update Record High for Third Consecutive Term, Dividend Raised by 15 yen
NAGANO KEIKI , 9% Decrease in Ordinary Profit for The Current Fiscal Year
Yamadai, Last Fiscal Year Net Income Loss Widened in Downward Revision, 40% Deficit Against Net Assets, Dividend Revised down by 10 yen
KIMURA, 19% Decrease in Ordinary Profit for The Current Fiscal Year
Taisei Lamick, 27% Decrease in Ordinary Profit for The Current Fiscal Year
Togami Electric Mfg, 0.3% Increase in Ordinary Profit, Update Record High for Second Consecutive Term